PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rail industry urged to consider safety risks of space weather

Rail industry urged to consider safety risks of space weather
2023-12-11
(Press-News.org) Train accidents could be caused by solar storms switching signalling from red to green according to new research examining the impact of space weather.

Solar storms can trigger powerful magnetic disturbances on Earth, creating geomagnetically induced currents (GICs) which could potentially interfere with electricity transmission and distribution grids.

A team led by PhD researcher Cameron Patterson and Professor Jim Wild from Lancaster University modelled how GICs flowed through the track circuits of AC electrified lines powered with overhead cables.

Using two routes - the Preston to Lancaster section of the West Coast Main Line, and the Glasgow to Edinburgh line – the team modelled how GICs induced in the rails could cause rail signalling to malfunction.

There are more than 50,000 signalling track circuits in the UK, where the signal is controlled by an electrical circuit between the rails.

Physics PhD researcher Cameron Patterson said: “Crucially, our research suggests that space weather is able to flip a signal in either direction, turning a red signal green or a green signal red.  This is obviously very significant from a safety perspective.

“By building a computer model of the signalling track circuits using realistic specifications for the various components of the system, we found that space weather events capable of triggering faults in these track circuits are expected in the UK every few decades.”

Cameron’s earlier research in the journal Space Weather explored what is known in the industry as “right side” failures, where the signal is switched from green to red.

This is a fail-safe scenario but the converse “wrong side” failures - when the signal goes from red to green - are much more hazardous.

This latest study, also in Space Weather, shows that “wrong side” failures could occur at a lower geoelectric field strength than for “right side” failures, meaning a weaker geomagnetic storm could more easily trigger “wrong side” failures.

It was estimated that, for the lines studied, “wrong side” failures could occur due to a geomagnetic storm with a frequency of about one or two decades.

The analysis was also performed for once-in-a-century extreme event, and it was shown that it could potentially cause many malfunctions of both typs throughout the lines in both directions of travel, depending on the number of trains on the line at that time.

Cameron said: “When we experience severe space weather which happens every few decades or extreme space weather seen every century or two, then there is a potential for significant signalling misoperation, which has an obvious safety impact.”

There have been several examples of space weather impacting power grids in the last few decades, including power outages affecting millions across the Canadian province of Quebec in 1989 and the Swedish city of Malmo in 2003.

There are also historic examples of space weather interfering with railway signalling as far back as the nineteenth century. And in 1859, a massive solar eruption triggered a geomagnetic storm that disrupted telegraph lines across the world. The team also assessed the impact of a solar storm of the size of the 1859 event, predicting that it would cause widespread problems with signalling on both lines studied.

Cameron said: “Our research shows that space weather poses a serious, if relatively rare, risk to the rail signalling system, which could cause delays or even have more critical, safety implications.  This natural hazard needs to be taken seriously.  By their nature, high-impact, low-frequency events are hard to plan for, but ignoring them is rarely the best way forward.

Jim Wild, Professor of Space Physics at Lancaster University said: “Other industries such as aviation, electricity generation and transmission, and the space sector are considering the risks to their operations, and exploring how these might be mitigated. It’s important that the rail sector is included in this planning.”

“As our understanding of the space weather hazard improves, it’s possible to consider how to reduce the risks. In future, we could see space weather forecasting being used make decisions about limiting railway operations if an extreme event is expected, just as meteorological forecasts are used currently.

Severe space weather is included in the UK Government’s National Risk Register for Civil Emergencies which lists the risk posed to the UK’s economy and society as “significant”.

 

END

[Attachments] See images for this press release:
Rail industry urged to consider safety risks of space weather Rail industry urged to consider safety risks of space weather 2 Rail industry urged to consider safety risks of space weather 3

ELSE PRESS RELEASES FROM THIS DATE:

Technology not growing fast enough to decarbonize steel and cement industries by 2050

2023-12-11
Steel and cement are two materials that no society can do without. Their production comes with a significant carbon footprint, however. To meet zero-emission targets under the Paris Agreement, countries, cities, and industries are depending on new large-scale infrastructure for CO2 transport and storage, renewable electricity and green hydrogen. A new study by researchers at the National Institute for Environmental Studies, Japan, and the University of Cambridge, United Kingdom, shows that the current rate of deployment of this infrastructure is insufficient. The study ...

Landscape for AML patients evolving rapidly as research discoveries advance new treatments

Landscape for AML patients evolving rapidly as research discoveries advance new treatments
2023-12-11
MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 10, 2023, AT 7:30 P.M. ET) – The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.  “We’ve seen more progress during the past 10 years than the previous four decades combined,” said Justin M. Watts, M.D., Sylvester hematologist, associate professor of medicine, and Pap Corps Early Career ...

'Exceptional' results in phase III leukaemia trial

2023-12-11
University of Leeds news Embargo: 19:30 ET on Sunday 10 December 2023 / 00.30 GMT on Monday 11 December 2023 New personalised therapy improves survival for patients with CLL leukaemia Personalised treatment for the most common form of adult leukaemia helps patients survive for longer and stay in remission, a phase III trial has found. The trial, by the University of Leeds, has been identified as groundbreaking research by the New England Journal of Medicine and the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, where ...

Cell therapy appears safe and effective for lymphoma in remission

Cell therapy appears safe and effective for lymphoma in remission
2023-12-11
DOWNLOADABLE VIDEO HERE MIAMI, FLORIDA (EMBARGOED UNTIL SUNDAY, DEC. 10, 2023 AT 8:00 P.M. ET) – A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. While the study doesn’t answer the question of whether cell therapy in remission is the right choice, it does say that it’s not the wrong choice. “I ...

ASH: Novel combination therapy significantly reduces spleen volume in patients with myelofibrosis

2023-12-10
SAN DIEGO ― Combining the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing enlarged spleens – a major indicator of clinical improvement – compared with standard-of-care ruxolitinib monotherapy for adult patients with intermediate or high-risk myelofibrosis, a rare bone marrow cancer, according to results of the Phase III TRANSFORM-1 trial reported by researchers from The University of Texas MD Anderson Cancer Center. Data from the global, randomized, placebo-controlled ...

ASH: Novel menin inhibitors show promise for patients with advanced acute myeloid leukemias

2023-12-09
SAN DIEGO ― Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations. Results from the studies were shared today in oral presentations at the 2023 American Society of Hematology (ASH) Annual Meeting. More information on all ASH Annual Meeting content from MD Anderson can be found at MDAnderson.org/ASH. Menin inhibitor monotherapy ...

ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder

ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder
2023-12-09
SAN DIEGO ― The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis, according to results of the Phase II SUMMIT trial reported by researchers at The University of Texas MD Anderson Cancer Center. The findings, presented today at the 2023 American Society of Hematology (ASH) Annual Meeting, demonstrate that all participants treated with bezuclastinib achieved at least a 50% reduction in markers of disease burden and 63% reported their disease symptoms eased within 12 weeks. That number increased to 78% after ...

New Sylvester cancer study provides insight into underlying gene mutations in myelodysplastic syndromes

2023-12-09
EMBARGOED UNTIL DECEMBER 9, 2023, AT 12:45 P.M. ET A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations provides insight into the underlying mechanisms of gene mutations commonly seen in patients with myelodysplastic syndromes (MDS) and other myeloid neoplasms. Their findings, to be presented at ASH 2023, the American Society of Hematology’s annual meeting in Santa Diego, Dec. 9-12, could lead to development of more effective drug combinations ...

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

2023-12-09
SAN DIEGO – Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct binding mechanism to target CD19, show a 100 percent complete response (CR) rate at the higher dose levels studied in the trial, according to researchers from the University of Pennsylvania Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center. The findings were published today in Molecular Cancer and presented at the 65th American Society of Hematology (ASH) Annual Meeting ...

Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL

2023-12-09
Older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who were not good candidates for the standard treatment of intensive chemotherapy had a median overall survival (OS) of 6.5 years on an alternate regimen of dasatinib and blinatumomab.  These long-term results from the S1318 clinical trial will be presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego on December 9 (abstract 1499). Anjali S. Advani, MD, a SWOG investigator at Cleveland Clinic Cancer Institute, led the study, with ...

LAST 30 PRESS RELEASES:

Climate change is a health emergency too

Chronic stress accelerates colorectal cancer progression by disrupting the balance of gut microbiota, new study shows

Brazilian study identifies potential targets for treatment of visceral leishmaniasis

Using AI and iNaturalist, scientists build one of the highest resolution maps yet of California plants

Researchers identify signs tied to more severe cases of RSV

Mays Cancer Center radiation oncologist recognized as outstanding mentor to next generation leaders

Hitting the bull’s eye to target ‘undruggable’ diseases – researchers reveal new levels of detail in targeted protein degradation

SCAI publishes expert consensus statement on managing patients with ST-elevated myocardial infarction

Engineering perovskite materials at the atomic level paves way for new lasers, LEDs

Kessler Foundation 2024 Survey highlights key strategies for hiring and supporting workers with disabilities in the hospitality industry

Harnessing protons to treat cancer

Researchers identify neurodevelopmental symptoms that indicate genetic disorders

Electronic nudges to increase influenza vaccination in patients with chronic diseases

Plant stem cells: Better understanding the biological mechanism of growth control

Genomic study identifies human, animal hair in ‘man-eater’ lions’ teeth

These 19th century lions from Kenya ate humans, DNA collected from hairs in their teeth shows

A potential non-invasive stool test and novel therapy for endometriosis

Racial and ethnic disparities in age-specific all-cause mortality during the COVID-19 pandemic

Delft scientists discover how innate immunity envelops bacteria

Workforce diversity is key to advancing One Health

Genome Research publishes a special issue on innovations in computational biology

A quick and easy way to produce anode materials for sodium-ion batteries using microwaves

‘Inside-out’ galaxy growth observed in the early universe

Protein blocking bone development could hold clues for future osteoporosis treatment

A new method makes high-resolution imaging more accessible

Tiny magnetic discs offer remote brain stimulation without transgenes

Illuminating quantum magnets: Light unveils magnetic domains

Different types of teenage friendships critical to wellbeing as we age, scientists find

Hawaii distillery project wins funding from Scottish brewing and distilling award

Trinity researchers find ‘natural killer’ cells that live in the lung are ready for a sugar rush

[Press-News.org] Rail industry urged to consider safety risks of space weather